13.12
Schrodinger Inc stock is traded at $13.12, with a volume of 1.32M.
It is up +4.96% in the last 24 hours and down -1.80% over the past month.
Schrodinger Inc is a healthcare-based software company. It offers software solutions designed to support and accelerate the discovery, design, and optimization of molecules. The company operates in two reportable segments: Software and Drug Discovery. The software segment is focused on selling software to transform drug discovery across the life sciences industry, as well as to customers in materials science industries. The drug discovery segment is focused on generating revenue from a diverse portfolio of preclinical and clinical programs, internally and through collaborations, that have various stages of discovery and development. The majority of the company's revenue is derived from the Software segment. Geographically, it derives the maximum revenue from the United States.
See More
Previous Close:
$12.50
Open:
$12.81
24h Volume:
1.32M
Relative Volume:
1.07
Market Cap:
$966.48M
Revenue:
$193.35M
Net Income/Loss:
$-177.58M
P/E Ratio:
-5.3551
EPS:
-2.45
Net Cash Flow:
$-172.43M
1W Performance:
+11.19%
1M Performance:
-1.80%
6M Performance:
-30.84%
1Y Performance:
-37.76%
Schrodinger Inc Stock (SDGR) Company Profile
Name
Schrodinger Inc
Sector
Industry
Phone
503-299-1150
Address
1540 BROADWAY, NEW YORK, NY
Compare SDGR vs VEEV, TEM, BTSG, HQY, WAY
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
SDGR
Schrodinger Inc
|
13.12 | 920.81M | 193.35M | -177.58M | -172.43M | -2.45 |
|
VEEV
Veeva Systems Inc
|
188.48 | 30.56B | 3.08B | 860.33M | 1.35B | 5.1463 |
|
TEM
Tempus Ai Inc
|
51.29 | 9.19B | 1.27B | -245.03M | -245.36M | -1.4071 |
|
BTSG
Brightspring Health Services Inc
|
41.96 | 7.33B | 11.99B | 24.18M | 234.31M | 0.2956 |
|
HQY
Healthequity Inc
|
81.15 | 6.87B | 1.15B | 96.70M | -161.99M | 1.09 |
|
WAY
Waystar Holding Corp
|
26.93 | 5.09B | 906.14M | -52.62M | 89.62M | -0.3621 |
Schrodinger Inc Stock (SDGR) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-15-25 | Upgrade | BofA Securities | Neutral → Buy |
| Sep-30-25 | Initiated | Goldman | Neutral |
| Aug-15-25 | Downgrade | Citigroup | Buy → Neutral |
| Aug-14-25 | Initiated | Barclays | Overweight |
| Jul-03-25 | Resumed | Morgan Stanley | Equal-Weight |
| Jul-02-24 | Initiated | Leerink Partners | Outperform |
| Dec-05-23 | Initiated | KeyBanc Capital Markets | Overweight |
| May-05-23 | Resumed | Piper Sandler | Overweight |
| Dec-19-22 | Initiated | Goldman | Neutral |
| Mar-01-22 | Initiated | Citigroup | Buy |
| Nov-19-21 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Nov-19-21 | Initiated | Piper Sandler | Overweight |
| Nov-11-21 | Downgrade | BofA Securities | Buy → Neutral |
| Oct-13-21 | Initiated | Berenberg | Buy |
| Sep-01-21 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| May-25-21 | Initiated | Craig Hallum | Buy |
| Nov-23-20 | Upgrade | BofA Securities | Neutral → Buy |
| Oct-12-20 | Upgrade | Jefferies | Hold → Buy |
| Mar-02-20 | Initiated | BMO Capital Markets | Outperform |
| Mar-02-20 | Initiated | Jefferies | Hold |
| Mar-02-20 | Initiated | Morgan Stanley | Equal-Weight |
View All
Schrodinger Inc Stock (SDGR) Latest News
Schrodinger, Inc. $SDGR Shares Sold by ARK Investment Management LLC - MarketBeat
[144] Schrodinger, Inc. SEC Filing - Stock Titan
Vanguard Group Inc. Has $127.16 Million Holdings in Schrodinger, Inc. $SDGR - MarketBeat
Schrodinger (NASDAQ: SDGR) CEO gets options, sells shares under 10b5-1 - Stock Titan
Schrodinger (SDGR) CFO receives new stock options and RSU grants - Stock Titan
Schrodinger (NASDAQ: SDGR) EVP granted stock options and RSU awards - Stock Titan
Schrodinger (NASDAQ: SDGR) CTO Lorton receives new stock and option awards - Stock Titan
Schrodinger (SDGR) CAO Jenny Herman receives new RSU and option awards - Stock Titan
Schrodinger (SDGR) executive granted 48,500 options and sells shares for taxes - Stock Titan
Equity grants to Schrodinger (NASDAQ: SDGR) officer include options and RSUs - Stock Titan
Schrodinger (SDGR) executive receives new RSUs and stock option grant - Stock Titan
Schrödinger at TD Cowen Conference: Transition to Hosted Services By Investing.com - Investing.com Canada
Schrodinger, Inc. (SDGR) Stock Analysis: Investors Eye a Potential 93% Upside Amid Market Turbulence - DirectorsTalk Interviews
Schrodinger, Inc. (NASDAQ:SDGR) Given Average Rating of "Hold" by Brokerages - MarketBeat
Schrodinger, Inc. (SDGR) Transition to Licensing Model Triggers Robust Revenue Growth - Finviz
Schrödinger, Inc. (SDGR) Transition to Licensing Model Triggers Robust Revenue Growth - Insider Monkey
SDGR Stock Price, Quote & Chart | SCHRODINGER INC (NASDAQ:SDGR) - ChartMill
Schrödinger (SDGR) Valuation After 2025 Results And Shift To Hosted Licensing Model - simplywall.st
Assessing Schrödinger (SDGR) Valuation After Full Year 2025 Earnings And AI Platform Progress - Yahoo Finance
Does Schrödinger’s 2025 Revenue Surge And Narrower Loss Reshape The Bull Case For SDGR? - simplywall.st
SDGR Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Analysts Offer Insights on Healthcare Companies: Schrodinger (SDGR), Medline, Inc. Class A (MDLN) and Silence Therapeutics (SLN) - The Globe and Mail
Schrodinger Inc. (SDGR) Stock Falls on Q4 2025 Earnings - Quiver Quantitative
Schrodinger (NASDAQ:SDGR) Shares Gap Up on Better-Than-Expected Earnings - MarketBeat
Schrödinger, Inc. 2025 Q4ResultsEarnings Call Presentation (NASDAQ:SDGR) 2026-02-26 - Seeking Alpha
Schrodinger Q4 Earnings Call Highlights - MarketBeat
Schrodinger Inc (SDGR) Q4 2025 Earnings Call Highlights: Strong Revenue Growth Amid Transition Challenges - GuruFocus
Schrödinger (SDGR) Reports Strong 2025 Revenue Growth and Strate - GuruFocus
Earnings Call Summary | Schrodinger(SDGR.US) Q4 2025 Earnings Conference - 富途牛牛
Schrodinger (NASDAQ:SDGR) Announces Quarterly Earnings Results, Beats Estimates By $0.57 EPS - MarketBeat
Schrodinger Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Schrödinger Reports Fourth Quarter and Full-Year 2025 Financial Results - PharmiWeb.com
SDGR: 23% revenue growth in 2025, strong ACV, and hosted transition drive future profitability - TradingView
Earnings call transcript: Schrödinger Q4 2025 revenue beats forecast, shares rise - Investing.com Nigeria
Earnings call transcript: Schrödinger Q4 2025 revenue beats forecast, shares rise By Investing.com - Investing.com South Africa
SDGR: Revenue up 23% to $255.9M, net loss narrows, and cash reserves remain strong - TradingView
Schrödinger, Inc. (SDGR) Stock Analysis: Unveiling a 126.78% Potential Upside in the Healthcare Sector - DirectorsTalk Interviews
Schrödinger to Participate in Upcoming March 2026 Investor Conferences - BioSpace
Earnings Preview For Schrodinger - Benzinga
Schrödinger to Participate in Upcoming Investor Conferences - PharmiWeb.com
Schrodinger (NASDAQ:SDGR) Reaches New 52-Week LowShould You Sell? - MarketBeat
SDGR Technical Analysis & ETF Price Forecast - Intellectia AI
Schrödinger, Inc. Hits New 52-Week Low at USD 11.11 - Markets Mojo
Schrodinger's Pivotal Earnings Report Approaches () - aktiencheck.de
Jupiter Asset Management Ltd. Acquires Shares of 234,625 Schrodinger, Inc. $SDGR - MarketBeat
Top 3 health care stocks that could lead to your biggest gains in Q1 - MSN
Top 3 Health Care stocks That Could Lead To Your Biggest Gains In Q1 - Fidelity
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - PharmiWeb.com
Schrodinger (SDGR) Projected to Post Earnings on Wednesday - MarketBeat
Schrodinger, Inc. (SDGR) Investor Outlook: Unpacking A 123% Potential Upside - DirectorsTalk Interviews
How (SDGR) Movements Inform Risk Allocation Models - Stock Traders Daily
Schrodinger Inc Stock (SDGR) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):